These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11604557)

  • 1. Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo.
    Takeda Y; Yoshizaki I; Nonaka Y; Yanagie H; Matsuzawa A; Eriguchi M
    Anticancer Drugs; 2001 Sep; 12(8):691-8. PubMed ID: 11604557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
    Fujimoto-Ouchi K; Tanaka Y; Tominaga T
    Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical efficacy of low-dose weekly docetaxel combined with oral 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced or metastatic breast cancer: a pilot trial].
    Harada Y; Ohuchi N; Ohnuki K; Amano G; Yoshida R; Furuta A; Ikegaki H; Kijima G; Satomi S
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):579-84. PubMed ID: 10791000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined effects of docetaxel and fluoropyrimidines on tumor growth and expression of interleukin-6 and thymidine phosphorylase in breast cancer xenografts.
    Yamamoto S; Kurebayashi J; Kurosumi M; Kunisue H; Otsuki T; Tanaka K; Sonoo H
    Cancer Chemother Pharmacol; 2001 Oct; 48(4):283-8. PubMed ID: 11710628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
    Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of recurrent breast cancer with carcinoma erysipeloides responding to sequential therapy with docetaxel (TXT) and doxifluridine (5'-DFUR) accompanied by leucovorin (LV)].
    Hara Y; Kawasaki T; Yabata E; Gen T; Jibiki M; Kudoh A; Noguchi N; Igarashi K; Kikuchi M
    Gan To Kagaku Ryoho; 2000 Apr; 27(4):627-31. PubMed ID: 10791009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of thymidine phosphorylase by neoadjuvant chemotherapy in primary breast cancer.
    Toi M; Bando H; Horiguchi S; Takada M; Kataoka A; Ueno T; Saji S; Muta M; Funata N; Ohno S
    Br J Cancer; 2004 Jun; 90(12):2338-43. PubMed ID: 15150550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the polyamine catabolic enzymes SSAT and SMO in the synergistic effects of standard chemotherapeutic agents with a polyamine analogue in human breast cancer cell lines.
    Pledgie-Tracy A; Billam M; Hacker A; Sobolewski MD; Woster PM; Zhang Z; Casero RA; Davidson NE
    Cancer Chemother Pharmacol; 2010 May; 65(6):1067-81. PubMed ID: 19727732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic effects of docetaxel and S-1 by modulating the expression of metabolic enzymes of 5-fluorouracil in human gastric cancer cell lines.
    Wada Y; Yoshida K; Suzuki T; Mizuiri H; Konishi K; Ukon K; Tanabe K; Sakata Y; Fukushima M
    Int J Cancer; 2006 Aug; 119(4):783-91. PubMed ID: 16557585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.
    Chou TC; Otter GM; Sirotnak FM
    Cancer Chemother Pharmacol; 1996; 37(3):222-8. PubMed ID: 8529281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative antitumor activity of 5-fluorouracil and its prodrugs in combination with hyperthermia in vitro.
    Shiiki S; Fuchimoto S; Iwagaki H; Akazai Y; Matsubara N; Watanabe T; Orita K
    Acta Med Okayama; 1991 Oct; 45(5):339-45. PubMed ID: 1836706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative antitumor activity of 5-fluorouracil and 5'-deoxy-5-fluorouridine in combination with interferon gamma in renal cell carcinoma cell lines.
    Ikemoto S; Sugimura K; Yoshida N; Kuratsukuri K; Wada S; Nakatani T
    Anticancer Res; 2002; 22(6C):4023-7. PubMed ID: 12553027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxanes and capecitabine in combination: rationale and clinical results.
    Maher JF; Villalona-Calero MA
    Clin Breast Cancer; 2002 Jan; 2(4):287-93. PubMed ID: 11899360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of thymidine phosphorylase expression and enhancement of efficacy of capecitabine or 5'-deoxy-5-fluorouridine by cyclophosphamide in mammary tumor models.
    Endo M; Shinbori N; Fukase Y; Sawada N; Ishikawa T; Ishitsuka H; Tanaka Y
    Int J Cancer; 1999 Sep; 83(1):127-34. PubMed ID: 10449619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma, intestine and tumor levels of 5-fluorouracil in mice bearing L1210 ascites tumor following oral administration of 5-fluorouracil, UFT (mixed compound of tegafur and uracil), carmofur and 5'-deoxy-5-fluorouridine.
    Ooi A; Ohkubo T; Higashigawa M; Kawasaki H; Kakito H; Kagawa Y; Kojima M; Sakurai M
    Biol Pharm Bull; 2001 Nov; 24(11):1329-31. PubMed ID: 11725974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer.
    Kim R; Minami K; Nishimoto N; Toge T
    Int J Oncol; 2001 Feb; 18(2):363-7. PubMed ID: 11172605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
    Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antitumor activity of 5'-deoxy-5-fluorouridine (Furtulon) by taxane in human gastric cancer xenografts.
    Sawada N; Nose T; Ishikawa T; Yutaka T
    Oncol Rep; 2005 Jul; 14(1):53-7. PubMed ID: 15944767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential inhibition of bone metastases by 5'-deoxy-5-fluorouridine and capecitabine in the 4T1/luc mouse breast cancer model.
    Hiraga T; Hata K; Ikeda F; Kitagaki J; Fujimoto-Ouchi K; Tanaka Y; Yoneda T
    Oncol Rep; 2005 Sep; 14(3):695-9. PubMed ID: 16077977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.